Federated Hermes
BNTX icon

Federated Hermes’s BioNTech BNTX Stock Holding History

Federated Hermes’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,000
Closed -$869K – 2057
2023
Q3 		$869K Buy
8,000
+3,000
+60% +$332K ﹤0.01% 1160
2023
Q2 		$540K Buy
5,000
+1,000
+25% +$112K ﹤0.01% 1343
2023
Q1 		$498K Buy
+4,000
New +$549K ﹤0.01% 1404

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Federated Hermes's BNTX Position: Q4 2023 in Review

Federated Hermes sold out of BioNTech (BNTX) in Q4 2023, closing a stake of 8,000 shares — an estimated $869K sold.

Federated Hermes first reported a position in BNTX in Q1 2023 and held it in 3 quarters. The position peaked at $869K in Q3 2023. 282 funds tracked by Wall St. Rank hold BNTX as of Q4 2023.

  • Federated Hermes reported no remaining BioNTech position as of Q4 2023 after selling out during the quarter.
  • Federated Hermes sold 8,000 BioNTech shares in Q4 2023, an estimated $869K.
  • Federated Hermes first reported a position in BioNTech in Q1 2023 and held it in 3 quarters.
  • Federated Hermes's BioNTech position peaked at $869K in Q3 2023.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q4 2023.

Based on Federated Hermes's 13F filing for Q4 2023, filed 31 Jan 2024.